According to the fifth edition of the WHO classification of tumors of the central nervous system (WHO CNS5),1 the median survival time of glioblastoma (GBM, IDH‐wildtype) failed to exceed 15 months.2, 3. Here, IDH1 is linked to central nervous system cancer.